Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German Merck To Double Fund Size And Broaden Corporate VC Focus

Executive Summary

Merck of Germany has decided to expand the activities of its corporate venture fund to include all aspects of its business rather than focusing on biopharma. Managing director of Merck Ventures Roel Bulthuis explains what led to the decision and why it won't affect Merck's commitment to innovation in healthcare, and may in fact boost productivity.

Advertisement

Related Content

Resilient US Rebif, Gonal-f Q2 Sales Allow German Merck To Up Forecast

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC065373

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel